Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) Stock Short Interest Falls 56.5%

Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) saw a large drop in short interest in the month of September. As of September 30th, there was short interest totaling 1,378,001 shares, a drop of 56.5% from the September 15th total of 3,166,158 shares. Based on an average trading volume of 43,882 shares, the days-to-cover ratio is currently 31.4 days.

Kyowa Kirin Price Performance

OTCMKTS KYKOF remained flat at $14.12 on Wednesday. 1,977 shares of the company were exchanged, compared to its average volume of 20,965. The company’s 50 day moving average price is $14.72 and its 200-day moving average price is $14.41. Kyowa Kirin has a twelve month low of $4.20 and a twelve month high of $15.90.

Analysts Set New Price Targets

Separately, Jefferies Financial Group lowered Kyowa Kirin to a “hold” rating in a report on Tuesday, September 8th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Reduce”.

About Kyowa Kirin

Kyowa Kirin Co, Ltd. is a Japan-based specialty pharmaceutical company that researches, develops, manufactures and markets prescription medicines. The company focuses on therapies for areas including oncology, immunology, nephrology, the central nervous system and rare diseases, with an emphasis on biologics and other innovative treatments.

Its products include Poteligeo (mogamulizumab), an antibody used in certain hematologic cancers and cutaneous T-cell lymphomas, and Crysvita (burosumab), a treatment for disorders involving abnormal phosphate regulation.